H1, which provides the largest global healthcare platform connecting healthcare professionals, announced today that it has acquired the Portland, Oregon-based company Carevoyance, which offers the best platform for physician segmentation, sales enablement and guidance to medical device sellers. The acquisition enables H1 to expand its presence in the medical device market and allows Carevoyance, which will continue to operate independently, as a subsidiary of H1, to include H1’s proprietary data in its product offering to deliver more value to customers. Both companies will continue to serve clients in their respective markets.
The transaction provides for synergies to expand the market presence of both companies. Carevoyance has a strong track record in evaluating healthcare data to unleash practical insights for life sciences, medical devices, and vendor partners to help those companies reach the right buyers. The company counts among its clients some of the largest medical device companies in the world, including Olympus, Nuvasive and Insightec. H1 has built the leading intelligence platform for healthcare providers around the world, searching academic data and medical claims data to discover the most relevant researchers or physicians based on any criteria.
H1’s world-class operations teams and professionals can help significantly accelerate Carevoyance’s growth. “Carevoyance has always had a unique focus on delivering useful information through software to give our customers a competitive advantage in the marketplace,” said Anatoly Geyfman, Founder of Carevoyance. “We are delighted with the opportunity to join forces with H1 and bring the best business intelligence to all life sciences teams. The combination of H1 and Carevoyance will enable customers to make excellent data-driven decisions at every stage of the product life cycle, from research to commercialization. “
“The acquisition of Carevoyance strategically accelerates H1’s entry into the medical device space and adds depth to our engineering and customer service teams,” said Ariel Katz, co-founder and CEO of H1. “Perhaps most importantly, after spending time with Anatoly and the rest of the Carevoyance team, we thought it would be a strong culture and together we can continue to drive the supply of a source of truthful HCP information to the life sciences industry. . “
Thanks To You